Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05983757 · ClinicalTrials.gov registry record · NA

Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe

A NA study of Ischemic Stroke, sponsored by Raul Nogueira.

Recruiting
Registry status
NA
Development phase
584
Enrollment target
4
Study locations

NCT05983757 is a NA study of Ischemic Stroke that is actively recruiting participants, run by Raul Nogueira. The registered enrollment target is 584 participants, below the 1,455-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (60% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05983757, a NA study of Ischemic Stroke, is actively recruiting participants, sponsored by Raul Nogueira.

RECRUITING
Registry status
NA
Development phase
584 participants
Enrollment target
4
Study locations

Study Summary

A phase III, randomized, multi-center, investigational, open label clinical trial that will examine whether treatment with endovascular thrombectomy is superior to standard medical therapy alone in patients who suffer a Distal Medium Vessel Occlusion Ischemic Stroke within 12 hours from time last seen well

Conditions Studied

Interventions

  • DEVICE Experimental: endovascular thrombectomy in patients who suffer a distal medium vessel occlusion
  • OTHER Standard medical management

Study Locations (4)

Georgia

  • Grady Health System - Atlanta

Iowa

  • UI Health Care Medical Center - Iowa City

Ohio

  • ProMedica - Toledo

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 584 participants
Start Date 2024-04-02
Est. Completion 2027-11
Phase NA

Sponsor

Raul Nogueira

1 total trials

What the Registry Record Tells You About NCT05983757

The ClinicalTrials.gov registry entry for NCT05983757 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 584 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,455-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (60% lower). The listed sponsor is Raul Nogueira, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 2 interventions - of which Experimental: endovascular thrombectomy in patients who suffer a distal medium vessel occlusion is the first listed.

NCT05983757 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Georgia, Iowa, Ohio.

Frequently Asked Questions

What is clinical trial NCT05983757 about?

NCT05983757 is a clinical study titled "Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe". A phase III, randomized, multi-center, investigational, open label clinical trial that will examine whether treatment with endovascular thrombectomy is superior to standard medical therapy alone in patients who suffer a Distal Medium Vessel Occlusion Ischemic Stroke within 12 hours from time last se...

What is the current status of trial NCT05983757?

This trial is currently recruiting. It is a NA study. The enrollment target is 584 participants. The study started on 2024-04-02. Estimated completion is 2027-11.

What conditions does trial NCT05983757 study?

This clinical trial studies the following conditions: Ischemic Stroke.

What interventions are being tested in trial NCT05983757?

The interventions under investigation include: Experimental: endovascular thrombectomy in patients who suffer a distal medium vessel occlusion (DEVICE), Standard medical management (OTHER).

Who is sponsoring clinical trial NCT05983757?

This trial is sponsored by Raul Nogueira, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05983757 being conducted?

This trial has 4 study locations across Georgia, Iowa, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.